penicillin g has been researched along with picibanil in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grimm, EA; Yagita, M | 1 |
Ahmed, SU; Furuichi, S; Moriya, Y; Nishikawa, H; Ohe, G; Okamoto, M; Oshikawa, T; Saito, M; Sato, M; Tano, T; Yoshida, H | 1 |
2 other study(ies) available for penicillin g and picibanil
Article | Year |
---|---|
Inhibition of in vitro LAK generation by OK-432.
Topics: Biological Products; Dose-Response Relationship, Drug; Humans; Immunity, Cellular; In Vitro Techniques; Interleukin-2; Killer Cells, Natural; Kinetics; Lymphocyte Activation; Penicillin G; Phytohemagglutinins; Picibanil; Time Factors | 1986 |
Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Chromatography, Affinity; Drug Screening Assays, Antitumor; Fas Ligand Protein; fas Receptor; Female; Fibrosarcoma; Interleukin-12; Interleukin-18; Killer Cells, Natural; Lipopolysaccharides; Lymphokines; Lymphoma; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Moloney murine leukemia virus; Neoplasm Transplantation; Penicillin G; Perforin; Picibanil; Pore Forming Cytotoxic Proteins; Spleen; Streptococcus pyogenes; Teichoic Acids; Th1 Cells; Th2 Cells; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2001 |